Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
This study is ongoing, but not recruiting participants.
Study NCT01415297   Information provided by Niiki Pharma Inc.

First Received on August 3, 2011.   Last Updated on December 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumors
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
NKP-1339
Sponsors listed in this trial
Niiki Pharma Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services